Sign Up to like & get
recommendations!
0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000010610
Abstract: Abstract In clinical practice, some IgA nephropathy (IgAN) patients show resistance to or are unable to achieve complete remission using steroids and/or immunosuppressants. The current study aimed to assess the efficacy and safety of tacrolimus…
read more here.
Keywords:
complete remission;
iga nephropathy;
remission;
partial remission ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-063407
Abstract: Introduction Major depressive disorder (MDD) affects 163 million people globally every year. Individuals who experience subsyndromal depressive symptoms during remission (ie, partial remission of MDD) are especially at risk for a return to a depressive…
read more here.
Keywords:
partially remitted;
pct;
remission;
trial ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Diabetes Care"
DOI: 10.2337/dc21-2543
Abstract: OBJECTIVE To evaluate whether indexes of glycemic variability may overcome residual β-cell secretion estimates in the longitudinal evaluation of partial remission in a cohort of pediatric patients with new-onset type 1 diabetes. RESEARCH DESIGN AND…
read more here.
Keywords:
remission;
partial remission;
clinical parameters;
type diabetes ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.825426
Abstract: The partial remission (PR) phase, a period experienced by most patients with type 1 diabetes (T1D) soon after diagnosis, is characterized by low insulin requirements and improved glycemic control. Given the great potential of this…
read more here.
Keywords:
partial remission;
phase;
type diabetes;
candidate biomarkers ... See more keywords